When sales top 100 mil p/a in a couple of years for BSM alone and when you look at the huge mark up on that product and when Breastsling and hernia products come closer to fruition and/or diabetes / bone regeneration products ...........
330 mil might look quite cheap then
Not saying that this company will become another Cochlear but not saying it can't or won't either.
When sales top 100 mil p/a in a couple of years for BSM alone...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.22 |
Change
-0.030(1.33%) |
Mkt cap ! $921.4M | |||
| Open | High | Low | Value | Volume |
| $2.20 | $2.24 | $2.19 | $1.727M | 779.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87 | $2.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.23 | 9011 | 3 |
View Market Depth
| Last trade - 16.10pm 04/12/2024 (20 minute delay) ? |
| PNV (ASX) Chart |